• Text size
  • A
  • A
  • A
Your spotlight on local services
menu

Experiences of DPYD Testing

22/02/2022

Genomic Medicine Service Alliance want to engage with cancer patients who started chemotherapy treatment since November 2020 to listen to your experience of DPYD testing.

DPD testing identifies patients at higher risk of an adverse reaction to the most used chemotherapy treatments. The two most used chemotherapy treatments are either 5-FU (5-fluorouracil) or capecitabine, so if you started chemotherapy treatment after November 2020, then you will have been DYPD tested, as part of your consent to treatment.

Testing helps to identify patients who can be treated more safely with a lower drug dose and is routine practice.

If you received treatment before November 2020 then you are not DPYD tested.

They would love to hear from you so if you would like to share your thoughts and opinions, please contact the NHS North West Genomic Medicine Service Alliance by email in the first instance, to Barbara.coleman@mft.nhs.uk by Friday 11th March 2022.

Recent

Find Our Facebook Page

Get in touch

Tell us your views about local health and social care services:

Telephone0300 111 0007

Email: info@healthwatchsthelens.co.uk

Twitter: @HWStHelens

Click here to sign up for our e newsletter


Become a member

Patient Opinion - Your Stories in St Helens